Literature DB >> 14551760

Normalized regional brain atrophy measurements in multiple sclerosis.

Robert Zivadinov1, Laura Locatelli, Barbara Stival, Alessio Bratina, Attilio Grop, Davide Nasuelli, Ozana Brnabic-Razmilic, Marino Zorzon.   

Abstract

There is still a controversy regarding the best regional brain atrophy measurements in multiple sclerosis (MS) studies. The aim of this study was to establish whether, in a cross-sectional study, the normalized measurements of regional brain atrophy correlate better with the MRI-defined regional brain lesions than the absolute measurements of regional brain atrophy. We assessed 45 patients with clinically definite relapsing-remitting (RR) MS (median disease duration 12 years), and measured T1-lesion load (LL) and T2-LL of frontal lobes and pons, using a reproducible semi-automated technique. The regional brain parenchymal volume (RBPV) of frontal lobes and pons was obtained by use of a computerized interactive program, which incorporates semi-automated and automated segmentation processes. A normalized measurement, the regional brain parenchymal fraction (RBPF), was calculated as the ratio of RBPV to the total volume of the parenchyma and the cerebrospinal fluid (CSF) in the frontal lobes and in the region of the pons. The total regional brain volume fraction (TRBVF) was obtained after we had corrected for the total volume of the parenchyma and the CSF in the frontal lobes and in the region of the pons for the total intracranial volume. The mean coefficient of variation (CV) for RBPF of the pons was 1% for intra-observer reproducibility and 1.4% for inter-observer reproducibility. Generally, the normalized measurements of regional brain atrophy correlated with regional brain volumes and disability better than did the absolute measurements. RBPF and TRBVF correlated with T2-LL of the pons (r=-0.37, P=0.011, and r= -0.40, P=0.0005 respectively) and with T1-LL of the pons (r=-0.27, P=0.046, and r=-0.31, P=0.04, respectively), whereas RBPV did not (r=-0.18, P = NS). T1-LL of the frontal lobes was related to RBPF (r=-0.32, P=0.033) and TRBVF (r=-0.29, P=0.05), but not to RBPV (R=-0.27, P= NS). There was only a trend of correlation between T2-LL of the frontal lobes and RBPF (r=-0.27, P=0.06) and TRBVF (r=-0.28, P=0.057), and no correlation with RBPV (r=-0.23, P= NS). The magnitude of correlation between the expanded disability status scale (EDSS) and pontine and frontal lobe RBPF and TRBVF was more than twice as high as the correlation between EDSS and RBPV of the same regions. These data suggest that normalized regional brain atrophy measurements are preferable to absolute regional measurements in cross-sectional studies.

Entities:  

Mesh:

Year:  2003        PMID: 14551760     DOI: 10.1007/s00234-003-1101-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  33 in total

1.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

2.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Authors:  J L Whitwell; W R Crum; H C Watt; N C Fox
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

Authors:  D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; N Parker; S Kurth; S D Horn
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

4.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood.

Authors:  A Pfefferbaum; D H Mathalon; E V Sullivan; J M Rawles; R B Zipursky; K O Lim
Journal:  Arch Neurol       Date:  1994-09

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

Authors:  C Liu; S Edwards; Q Gong; N Roberts; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

7.  Volumetric study of lobar atrophy in Pick complex and Alzheimer's disease.

Authors:  T Fukui; A Kertesz
Journal:  J Neurol Sci       Date:  2000-03-15       Impact factor: 3.181

8.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Authors:  R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

9.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

Authors:  J Grimaud; M Lai; J Thorpe; P Adeleine; L Wang; G J Barker; D L Plummer; P S Tofts; W I McDonald; D H Miller
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

10.  Detection of ventricular enlargement in patients at the earliest clinical stage of MS.

Authors:  P A Brex; R Jenkins; N C Fox; W R Crum; J I O'Riordan; G T Plant; D H Miller
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

View more
  4 in total

1.  Automated brain extraction from T2-weighted magnetic resonance images.

Authors:  Sushmita Datta; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

2.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

3.  Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.

Authors:  Omar Ghaffar; Laury Chamelian; Anthony Feinstein
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

4.  Spinal cord normalization in multiple sclerosis.

Authors:  Jiwon Oh; Michaela Seigo; Shiv Saidha; Elias Sotirchos; Kathy Zackowski; Min Chen; Jerry Prince; Marie Diener-West; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2014-03-05       Impact factor: 2.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.